Breast Cancer Connect
  • Saved
Breast cancer immunotherapy: Realities and advances

Breast cancer immunotherapy: Realities and advances

Source : https://pubmed.ncbi.nlm.nih.gov/39308754/

Breast cancer (BC) is the most common malignant tumor and the main cause of death in women worldwide. With increased knowledge regarding tumor escape mechanisms and advances in immunology, many...

Immunotherapy shows promise in breast cancer treatment, but challenges like resistance and modest response rates persist, requiring ongoing clinical trial evaluations and optimization for improved efficacy in combination with standard therapies.

 

  • Saved
Triple-negative breast cancer treatment with core-shell Magnetic@Platinium-Metal organic framework/epirubicin nano-platforms for chemo-photodynamic based combinational therapy: A review - PubMed

Triple-negative breast cancer treatment with core-shell Magnetic@Platinium-Metal organic framework/epirubicin nano-platforms for chemo-photodynamic based combinational therapy: A review - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39331917/

The combination of chemotherapy and photodynamic therapy (PDT), enabled by core-shell nano-platforms, is a promising method to improve cancer therapy by overcoming hypoxia and boosting drug penetration in breast tumor....

The M@Pt-MOF/EPI nano-platform enhances cancer treatment through effective chemo-photodynamic therapy, improving drug delivery and therapeutic efficacy in various cancers, particularly triple-negative breast cancer.

  • Saved
Revolutionizing triple-negative metastatic breast cancer treatment: sacituzumab Govitecan's role in advancing chemotherapy - PubMed

Revolutionizing triple-negative metastatic breast cancer treatment: sacituzumab Govitecan's role in advancing chemotherapy - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39238964/

In conclusion, Sacituzumab Govitecan shows potential as an innovative therapeutic option for breast cancer, particularly in metastatic breast cancer and triple-negative breast cancer, but it warrants additional research.

Sacituzumab Govitecan shows potential as an innovative therapeutic option for breast cancer, particularly in metastatic breast cancer and triple-negative breast cancer, but it warrants additional research.

  • Saved
Elucidating the Intricate Roles of Gut and Breast Microbiomes in Breast Cancer Metastasis to the Bone - PubMed

Elucidating the Intricate Roles of Gut and Breast Microbiomes in Breast Cancer Metastasis to the Bone - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39188104/

The present review describes association of gut and breast microbiomes with bone metastases. We have elaborated on the mechanisms utilized by breast and gut microbiomes that induce breast cancer metastasis,...

This review explores the role of gut and breast microbiomes in breast cancer bone metastasis, highlighting mechanisms and potential therapeutic targets including probiotics, antibiotics, and microbiome modulation to improve survival.

  • Saved

This meta-analysis compares prepectoral (PBR) and subpectoral breast reconstruction (SBR), showing PBR reduces animation deformity but increases the risks of rippling and seroma, with overall comparable complication rates.